EP Patent

EP3339329A1 — Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes

Assigned to Lek Pharmaceuticals dd · Expires 2018-06-27 · 8y expired

What this patent protects

The present invention relates to an efficient route of synthesis of iron (III) carboxymaltose complexes, in particular ferric carboxymaltose.

USPTO Abstract

The present invention relates to an efficient route of synthesis of iron (III) carboxymaltose complexes, in particular ferric carboxymaltose.

Drugs covered by this patent

Patent Metadata

Patent number
EP3339329A1
Jurisdiction
EP
Classification
—
Expires
2018-06-27
Drug substance claim
No
Drug product claim
No
Assignee
Lek Pharmaceuticals dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.